GILD Gilead Sciences Chart, History Price & Graph

Key Takeaways

• Gilead Sciences, Inc. (GILD) is in a short-term downtrend within a broader uptrend, with recent price action showing a pullback from yearly highs near $157.
• Key support cluster around $136.40–$137.40, with immediate resistance at $138.30–$139.20.
• Moving averages across all major periods (5- to 200-day) signal sell, with price trading below the 50-day simple moving average at $139.51.
• Momentum indicators are bearish: RSI(14) at 36.68 (sell), MACD(12,26) at -0.56 (sell), and Stochastic(9,6) at 32.57 (sell).
• Overall daily technical summary points to strong sell conditions, with potential oversold signals emerging.

Trend Analysis

Gilead Sciences, Inc. (GILD) has exhibited a robust uptrend over the past year, rallying from 52-week lows near $93.37 to highs above $157. However, recent price action reflects a corrective pullback, with the stock declining over the last three sessions and trading around $137. This movement aligns with a short-term bearish bias, as the price tests an ascending trendline support identified in trader analyses. The broader structure remains constructive from yearly lows, but failure to hold key supports could extend the correction.

Support and Resistance Levels

Traders are closely monitoring pivot-based levels derived from recent closes. Classic pivot points place the central pivot at $137.86, with first support (S1) at $137.35 and second support (S2) at $136.93, down to S3 at $136.42. Resistance begins at R1 $138.28, R2 $138.79, and R3 $139.21. Fibonacci pivots reinforce this, with S1 near $137.50 and R1 at $138.22. Additional resistance clusters around $140 from standard deviation bands and prior highs. A break below $136.40 could target deeper supports near $133, while a reclaim above $139 signals potential reversal.

Moving Averages

All simple and exponential moving averages from MA5 to MA200 indicate sell signals, underscoring downward pressure. The 5-day SMA stands at $137.80, 20-day at $138.56, 50-day at $139.51, 100-day at $139.18, and 200-day SMA at $140.62. Exponential averages are similarly bearish, with the 50-day EMA at $138.96. Price positioning below these levels, particularly the 50-day MA, confirms the short-term downtrend. A crossover above shorter-term MAs could shift sentiment toward neutral.

Momentum Indicators

Momentum has weakened, with a strong sell summary across 10 key oscillators. RSI(14) at 36.68 suggests oversold conditions nearing, potentially setting up for a bounce. MACD(12,26) remains negative at -0.56, reflecting bearish divergence. Stochastic(9,6) at 32.57 and Williams %R at -76.25 both signal sell, while CCI(14) at -110.40 indicates oversold momentum. ADX(14) at 22.41 points to moderate trend strength without extreme conviction. These readings align with recent consolidation and pullback behavior.

Tickeron’s AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast datasets including technical indicators, price patterns, and historical trends for stocks and ETFs like Gilead Sciences, Inc. (GILD). These signals identify potential buy or sell opportunities by recognizing recurring patterns in chart structures, momentum shifts, and volume anomalies. Traders rely on them to pinpoint entry/exit points, validate trend directions, and enhance decision-making amid market noise. Explore the AI insights to complement your technical review.

Technical Outlook and Key Levels to Watch

Market participants will watch for a potential stabilization near $136.40–$137.40 supports, where oversold RSI could prompt buying interest. A decisive break above $138.30–$139.20 resistance may signal resumption of the uptrend toward $140–$142. Conversely, violation of S3 at $136.42 opens the path to $133 and lower trendline tests. Monitor MACD for bullish crossover and volume for confirmation on any breakout. Short-term patterns like descending triangles suggest caution, with volatility contained by ATR(14) at 0.93.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.